Status of inhalable antimicrobial agents for lung infection: progress and prospects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Status of inhalable antimicrobial agents for lung infection: progress and prospects

Published:2021-05-04 Issue:10 Volume:15 Page:1251-1270
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Debnath Sujit Kumar¹,Srivastava Rohit¹,Debnath Monalisha²,Omri Abdelwahab³^ORCID

Affiliation:

1. Department of Biosciences and Bioengineering, Indian Institute of Technology, Bombay, Mumbai, India

2. School of Medical Sciences and Technology, Indian Institute of Technology, Kharagpur, India

3. Chemistry and Biochemistry, Laurentian University, Sudbury, Canada

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2021.1919514

Reference177 articles.

1. Targeted Delivery of Surface-Modified Nanoparticles: Modulation of Inflammation for Acute Lung Injury

2. Nanoparticle-based local antimicrobial drug delivery

3. Delivery of antibiotics to the respiratory tract: an update

4. Medical nanoparticles for next generation drug delivery to the lungs

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters;International Journal of Molecular Sciences;2024-04-25

2. Childhood Pneumonia in Low- and Middle-Income Countries: A Systematic Review of Prevalence, Risk Factors, and Healthcare-Seeking Behaviors;Cureus;2024-04-04

3. Opportunistic etiological agents causing lung infections: emerging need to transform lung-targeted delivery;Heliyon;2022-12

4. The future of inhalation therapy in chronic obstructive pulmonary disease;Current Research in Pharmacology and Drug Discovery;2022

5. Personalized antimicrobial therapy in critical and elderly patients;FARM HOSP;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3